Patent details

EP3294283 Title: SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING HEART FAILURE

Basic Information

Publication number:
EP3294283
PCT Application Number:
IB2016052633
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167223882
PCT Publication Number:
WO2016181284
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING HEART FAILURE
French Title of Invention:
SCHÉMA POSOLOGIQUE DU SACUBITRIL-VALSARTAN POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE
German Title of Invention:
SACUBITRIL-VALSARTAN-DOSIERSCHEMA ZUR BEHANDLUNG VON HERZVERSAGEN
SPC Number:

Dates

Filing date:
09/05/2016
Grant date:
08/03/2023
EP Publication Date:
21/03/2018
PCT Publication Date:
17/11/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/03/2023
EP B1 Publication Date:
08/03/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/05/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/08/2023
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

History of Owners

From:
01/03/2023
To:
04/08/2023

Name:
Novartis AG
Address:
Lichtstrasse 35, 4002 Basel, Switzerland (CH)

Inventor

1

Name:
RIZKALA, Adel Redmond
Address:
Switzerland (CH)

2

Name:
CHEN, Fabian
Address:
Switzerland (CH)

3

Name:
SHI, Victor Chengwei
Address:
Switzerland (CH)

Priority

Priority Number:
201562159703 P
Priority Date:
11/05/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/225; A61K 31/41; A61P 9/04;

Publication

European Patent Bulletin

1

Issue number:
202310
Publication date:
08/03/2023
Description:
Grant (B1)

2

Issue number:
202346
Publication date:
15/11/2023
Description:
Opposition procedure started

3

Issue number:
202402
Publication date:
10/01/2024
Description:
Opposition procedure started

4

Issue number:
202401
Publication date:
03/01/2024
Description:
Opposition procedure started

5

Issue number:
202311
Publication date:
15/03/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

6

Issue number:
202336
Publication date:
06/09/2023
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/04/2024
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages